The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 178, 5480 -5487
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, M.
Right arrow Articles by Min, W.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, M.
Right arrow Articles by Min, W.-P.
Right arrowPubmed/NCBI databases
*Substance via MeSH

Immune Modulation and Tolerance Induction by RelB-Silenced Dendritic Cells through RNA Interference1

Mu Li2,*, Xusheng Zhang2,*, Xiufen Zheng*, Dameng Lian*, Zhu-Xu Zhang*, Weiwen Ge, Jinming Yang||, Costin Vladau*, Motohiko Suzuki*, Dong Chen*, Robert Zhong*,{dagger},{ddagger},§, Bertha Garcia*,{dagger}, Anthony M. Jevnikar*,{dagger},{ddagger},§ and Wei-Ping Min3,*,{dagger},{ddagger},§

* Department of Surgery, Department of Pathology, and Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada; {dagger} Multi-Organ Transplant Program, London Health Sciences Centre, London, Ontario, Canada; {ddagger} Lawson Health Research Institute, London, Ontario, Canada; § Robarts Research Institute, London, Ontario, Canada; Advanced Proteomics Center, University of Medicine and Dentistry of New Jersey, Newark, NJ 07107; and || Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232

Dendritic cells (DC), the most potent APCs, can initiate the immune response or help induce immune tolerance, depending upon their level of maturation. DC maturation is associated with activation of the NF-{kappa}B pathway, and the primary NF-{kappa}B protein involved in DC maturation is RelB, which coordinates RelA/p50-mediated DC differentiation. In this study, we show that silencing RelB using small interfering RNA results in arrest of DC maturation with reduced expression of the MHC class II, CD80, and CD86. Functionally, RelB-silenced DC inhibited MLR, and inhibitory effects on alloreactive immune responses were in an Ag-specific fashion. RelB-silenced DC also displayed strong in vivo immune regulation. An inhibited Ag-specific response was seen after immunization with keyhole limpet hemocyanin-pulsed and RelB-silenced DC, due to the expansion of T regulatory cells. Administration of donor-derived RelB-silenced DC significantly prevented allograft rejection in murine heart transplantation. This study demonstrates for the first time that transplant tolerance can be induced by means of RNA interference using in vitro-generated tolerogenic DC.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by grants from the Heart and Stroke Foundation of Canada, the Roche Organ Transplantation Research Foundation, the Canadian Institutes of Health Research, and the Multi-Organ Transplant Program at the London Health Sciences Centre.

2 M.L. and X.Zha. contributed equally to this study.

3 Address correspondence and reprint requests to Dr. Wei-Ping Min, C9-136, London Health Sciences Centre-University Campus, 339 Windermere Road, London, Ontario, Canada N6A 5A5. E-mail address: weiping.min{at}uwo.ca

4 Abbreviations used in this paper: DC, dendritic cell; imDC, immature DC; mDC, mature DC; RNAi, RNA interference; siRNA, small interfering RNA; Treg, regulatory T cell; KLH, keyhole limpet hemocyanin.




This article has been cited by other articles:


Home page
BloodHome page
X. Zheng, C. Vladau, X. Zhang, M. Suzuki, T. E. Ichim, Z.-X. Zhang, M. Li, E. Carrier, B. Garcia, A. M. Jevnikar, et al.
A novel in vivo siRNA delivery system specifically targeting dendritic cells and silencing CD40 genes for immunomodulation
Blood, March 19, 2009; 113(12): 2646 - 2654.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Capini, M. Jaturanpinyo, H.-I Chang, S. Mutalik, A. McNally, S. Street, R. Steptoe, B. O'Sullivan, N. Davies, and R. Thomas
Antigen-Specific Suppression of Inflammatory Arthritis Using Liposomes
J. Immunol., March 15, 2009; 182(6): 3556 - 3565.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. E. Anderson, D. J. Swan, B. L. Sayers, R. A. Harry, A. M. Patterson, A. von Delwig, J. H. Robinson, J. D. Isaacs, and C. M. U. Hilkens
LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells
J. Leukoc. Biol., February 1, 2009; 85(2): 243 - 250.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Suzuki, X. Zheng, X. Zhang, M. Li, C. Vladau, T. E. Ichim, H. Sun, L. R. Min, B. Garcia, and W.-P. Min
Novel Vaccination for Allergy through Gene Silencing of CD40 Using Small Interfering RNA
J. Immunol., June 15, 2008; 180(12): 8461 - 8469.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Schmauss and M. Weis
Cardiac Allograft Vasculopathy: Recent Developments
Circulation, April 22, 2008; 117(16): 2131 - 2141.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.